2. Search Result
Search Result
Pathways Recommended: Antibody-drug Conjugate/ADC Related
Results for "

Antibody-Oligonucleotide Conjugates (AOCs)

" in MedChemExpress (MCE) Product Catalog:
Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-177568
    Mozistobart zoratolimod

    TAC-001

    		 CD22 Toll-like Receptor (TLR) Antibody-Oligonucleotide Conjugates (AOCs) Cancer
    Mozistobart zoratolimod is an antibody-oligonucleotide conjugate (AOC) composed of a humanized monoclonal antibody (HY-P990930 Mozistobart) targe ting CD22 linked to a TLR9 agonist. It is used for the study of cancer immunotherapy.
    Mozistobart zoratolimod
  • HY-177454
    Basivarsen linker

    		ADC Linker Others
    Basivarsen linker is a linker used in HY-177452 Zeleciment basivarsen for coupling a TfR1-binding Fab (HY-P990780 Zeleciment) and an antisense oligonucleotide. Zeleciment basivarsen is an antibody-oligonucleotide conjugate (AOC) designed to target mutant nuclear myotonic dystrophy protein kinase (DMPK) RNA for RHase H-mediated degradation to correct splicing. It is used for the study of myotonic dystrophy type 1 (DM1).
    Basivarsen linker
  • HY-177565
    Delpacibart etedesiran

    Del-desiran; AOC 1001

    		 Antibody-Oligonucleotide Conjugates (AOCs) Transferrin Receptor Inflammation/Immunology
    Delpacibart braxlosiran (Del-desiran), an antibody oligonucleotide conjugate (AOC), consists of a monoclonal antibody (Delpacibart) (HY-P990051) that binds to the transferrin receptor 1 (TfR1) conjugated with a siRNA targeting DMPK (DM1 protein kinase) mRNA. Delpacibart braxlosiran is used for the study of myotonic dystrophy type 1 (DM1) .
    Delpacibart etedesiran
  • HY-177566
    Delpacibart braxlosiran

    Del-brax; AOC 1020

    		 Antibody-Oligonucleotide Conjugates (AOCs) Transferrin Receptor Inflammation/Immunology
    Delpacibart braxlosiran (Del-brax), an antibody oligonucleotide conjugate (AOC), consists of a monoclonal antibody (Delpacibart) (HY-P990051) that binds to the transferrin receptor 1 (TfR1) conjugated with a siRNA targeting DUX4 (Double homeobox protein) mRNA. It is used for the study of Facioscapulohumeral Muscular Dystrophy (FSHD). The abnormal expression of DUX4 protein leads to changes in gene expression in muscle cells that are associated with the life-long, progressive loss of muscle function in patients with FSHD .
    Delpacibart braxlosiran

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: